Viromed Medical AG | WebDisclosure

Switch to English

10378	Sociétés
216369	Mots-clés
146018	Articles
114531	Communiqués

Accueil
Sociétés
Viromed Medical AG

COMMUNIQUÉ DE PRESSE

publié le 01/10/2025 à 09:33, il y a 7 mois 10 jours

Viromed Medical AG drives forward market launch of new products in the first half of 2025 and expands strategic partnerships
Viromed Medical AG reports successful first half of 2025 with strategic partnerships, acquisitions, and product developments in the medical technology sector

Strategic Partnerships Medical Technology Viromed Medical AG Cold Plasma Technology Market Launch
BRÈVE

publiée le 30/09/2025 à 11:52, il y a 7 mois 11 jours

Viromed Medical AG Initiates Cold Plasma Study on Living Lungs

Viromed Medical AG Cold Plasma Lung Study VAP Treatment Pulmonology Research
BRÈVE

publiée le 30/09/2025 à 11:52, il y a 7 mois 11 jours

Viromed Medical AG lance une étude sur le plasma froid dans des poumons vivants

Viromed Medical AG Plasma Froid Étude Pulmonaire Traitement VAP Recherche En Pneumologie
COMMUNIQUÉ DE PRESSE

publié le 30/09/2025 à 11:47, il y a 7 mois 11 jours

Viromed Medical AG launches in vivo and ex vivo study with cold plasma on living lungs
Viromed Medical AG launches in vivo and ex vivo study with cold plasma on living lungs. The study aims to revolutionize the treatment of ventilator-associated pneumonia and lung infections

Viromed Medical AG Ventilator-associated Pneumonia Cold Plasma Technology In Vivo Study Ex Vivo Study
BRÈVE

publiée le 23/09/2025 à 11:13, il y a 7 mois 18 jours

Viromed Medical AG Seeks Approval for PulmoPlas®

Antimicrobial Resistance Viromed Medical AG Cold Plasma Technology PulmoPlas® BfArM Approval
BRÈVE

publiée le 23/09/2025 à 11:13, il y a 7 mois 18 jours

Viromed Medical AG demande l'approbation de PulmoPlas®

Résistance Aux Antimicrobiens Viromed Medical AG Technologie Du Plasma Froid PulmoPlas® Approbation Du BfArM
COMMUNIQUÉ DE PRESSE

publié le 23/09/2025 à 11:08, il y a 7 mois 18 jours

Viromed Medical AG initiates approval process for PulmoPlas® with the Federal Institute for Drugs and Medical Devices (BfArM)
Viromed Medical AG initiates approval process for PulmoPlas® with the Federal Institute for Drugs and Medical Devices (BfArM), aiming to combat ventilator-associated pneumonia and antimicrobial resistance

Viromed Medical AG Ventilator-associated Pneumonia Cold Plasma Technology Approval Process PulmoPlas
BRÈVE

publiée le 18/09/2025 à 10:28, il y a 7 mois 23 jours

Viromed Medical AG Secures ISO 13485 Certification for ViroCAP® Launch

ISO 13485 Certification Viromed Medical AG Cold Plasma Technology ViroCAP® Launch Medical Device Manufacturer
BRÈVE

publiée le 18/09/2025 à 10:28, il y a 7 mois 23 jours

Viromed Medical AG obtient la certification ISO 13485 pour le lancement de ViroCAP®

Viromed Medical AG Technologie Du Plasma Froid Certification ISO 13485 Lancement De ViroCAP® Fabricant De Dispositifs Médicaux
COMMUNIQUÉ DE PRESSE

publié le 18/09/2025 à 10:23, il y a 7 mois 23 jours

Viromed Medical AG: Successful ISO 13485 certification paves the way for market launch of ViroCAP® in October 2025
Viromed Medical AG receives ISO 13485 certification, enabling market launch of ViroCAP® in October 2025 for dermatology, wound treatment, and veterinary use

Medical Devices ISO 13485 Certification Viromed Medical AG Market Launch ViroCAP

Les Echos

Publié le 11/05/2026 à 10:48, il y a 1 heure 6 minutes

GUILLEMOT CORPORATION | Weekly report share buyback from May 4 to May 8 2026
Publié le 11/05/2026 à 10:48, il y a 1 heure 6 minutes

GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 4 au 8 mai 2026
Publié le 11/05/2026 à 09:16, il y a 2 heures 38 minutes

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 28 avril 2026
Publié le 07/05/2026 à 19:15, il y a 3 jours 16 heures

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Publié le 07/05/2026 à 19:15, il y a 3 jours 16 heures

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 11/05/2026 à 09:05, il y a 2 heures 49 minutes

Ameriwest Outlines Multiple Additional Breccia Pipe-Style Targets at Bornite from Historical Soil Sampling and Mapping
Publié le 11/05/2026 à 08:05, il y a 3 heures 49 minutes

Tocvan Accelerates Gran Pilar: 5,000+ Meters Drilled to Date, Historic Workings Discovered on South Block, Pilot Progresses
Publié le 09/05/2026 à 01:55, il y a 2 jours 9 heures

Prospect Ridge Announces Board Resignation
Publié le 09/05/2026 à 01:40, il y a 2 jours 10 heures

Findev Inc. Issues Corrective Disclosure
Publié le 09/05/2026 à 01:30, il y a 2 jours 10 heures

Star Copper Announces Agreement with Zimtu Capital Corp.

Voir tout ACCESSWIRE

EQS Group

Publié le 11/05/2026 à 11:36, il y a 17 minutes

LION Smart and LEAPENERGY secure the performance of their storage containers through multiple guarantees
Publié le 11/05/2026 à 11:17, il y a 37 minutes

Aroundtown SA: Release of a capital market information
Publié le 11/05/2026 à 11:15, il y a 38 minutes

POS-Transaction in Own Shares
Publié le 11/05/2026 à 11:10, il y a 43 minutes

Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy
Publié le 11/05/2026 à 11:09, il y a 44 minutes

Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market